# Therapeutic Efficiency and Response to 2.0 GBq (55mCi) 177Lu-EB-PSMA in Patients With mCRPC

> **NCT04996602** · EARLY_PHASE1 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 2.0 GBq of 177Lu-EB-PSMA

## Key facts

- **NCT ID:** NCT04996602
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-14
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04996602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04996602, "Therapeutic Efficiency and Response to 2.0 GBq (55mCi) 177Lu-EB-PSMA in Patients With mCRPC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04996602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*